GlassScriptPhysician profile
Brooks H Potter
NPI 1629054580
$3,143.00
in general payments reported to CMS, 2019-2025
30 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $226 · 2021: $46.17 · 2022: $1,825 · 2023: $176 · 2024: $412 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,689.33 | 2022 | |
| Sanara Medtech INC. | $248.48 | 2024 | Celleraterx |
| Alfasigma USA, INC. | $137.79 | 2020 | |
| Boston Scientific Corporation | $114.85 | 2019 | |
| Bioventus LLC | $105.74 | 2019-2021 | |
| Globus Medical, INC. | $93.04 | 2022-2025 | Anthem, Clavicular Fracture Fixation |
| Anika Therapeutics, INC. | $91.86 | 2024-2025 | Integrity, X-Twist, Integrity Implant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $84.95 | 2020-2023 | Jublia |
| Sanofi-Aventis U.S. LLC | $84.39 | 2019-2023 | |
| Solventum Corporation | $65.75 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Vertex Pharmaceuticals Incorporated | $51.77 | 2025 | |
| Acera Surgical, INC. | $34.60 | 2023 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $30.13 | 2022-2025 | |
| Averitas Pharma INC. | $29.38 | 2024 | Qutenza |
| Orthofix Medical, INC. | $26.17 | 2023 | Physio-Stim |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23.33 | 2024 | Prostep Mica |
| Horizon Therapeutics Plc | $21.81 | 2023 | Krystexxa |
| Derma Sciences, INC. | $20.07 | 2019 | |
| Organogenesis INC. | $19.07 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.40 | 2024 | Nuzyra |
| Fidia Pharma USA INC. | $18.13 | 2019 | |
| Depuy Synthes Sales INC. | $16.61 | 2019 | |
| Kci USA, INC. | $16.38 | 2023 | Prevena |
| Allergan, INC. | $15.63 | 2020 | |
| Amgen INC. | $15.47 | 2025 | Krystexxa |
| Biocomposites INC | $14.96 | 2024 | |
| Ferring Pharmaceuticals INC. | $14.30 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $14.16 | 2019 | |
| Acell, INC. | $13.37 | 2020 | |
| Ethicon US, LLC | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooks Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.